395 results on '"Campbell, A. J."'
Search Results
2. Recurrent ETNK1 mutations in atypical chronic myeloid leukemia
3. Replacing Procarbazine with Dacarbazine in Escalated Beacopp Dramatically Reduces the Post Treatment Haematopoietic Stem and Progenitor Cell Mutational Burden in Hodgkin Lymphoma Patients with No Apparent Loss of Clinical Efficacy
4. The Complement System Mediates COVID-19 Endothelial Cell Injury, Modifying Cell Permeability
5. Clonal Dynamics after Haematopoietic Stem Cell Transplantation Using Genome-Wide Somatic Mutations
6. Diagnostic Utility of Whole Genome Sequencing in Adults with B-Other Acute Lymphoblastic Leukaemia
7. Differential and limited expression of mutant alleles in multiple myeloma
8. Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia
9. Clinical and biological implications of driver mutations in myelodysplastic syndromes
10. Bcl-2, Bcl-xL, and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells
11. Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells
12. High-scatter T cells: a reliable biomarker for malignant T cells in cutaneous T-cell lymphoma
13. How I treat essential thrombocythemia
14. The Longitudinal Dynamics and Natural History of Clonal Hematopoiesis
15. Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance
16. JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F–positive essential thrombocythemia
17. The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasms
18. Clonal Tracking By Whole Genome Sequencing Permits Comprehensive Mapping of the Genomic Landscape in Pre- and Post-Gene Therapy Sickle Cell Patients
19. Changes in Clonal Architecture Inform MPN Disease Course in Advance of Phenotypic Manifestations
20. Long-Term Clonal Dynamics upon Allogeneic Haematopoietic Stem Cell Transplantation Revealed Using Somatic Mutations As Clonal Tracking Marks in HSC Donor and Recipient Pairs
21. Antiphospholipid Antibody Profiles and Thrombotic Outcomes in the Starlet Cohort of Patients with Systemic Lupus Erythematosus
22. Clonal Dynamics of Normal Haematopoiesis with Human Ageing
23. MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort
24. Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes
25. Driver Mutation Acquisition in Utero and Childhood Followed By Lifelong Clonal Evolution Underlie Myeloproliferative Neoplasms
26. Whole-Genome Sequencing Reveals Evidence of Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Myeloma Precursor Disease
27. SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS
28. Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report
29. ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases
30. CCR4 versus CCR10 in human cutaneous TH lymphocyte trafficking
31. In Vivo Assessment of Intracellular Dynamics Comparing Injection Versus Oral Azacitidine in a Phase IIb Investigator Initiated Clinical Trial
32. Revealing the Impact of Recurrent and Rare Structural Variations in Multiple Myeloma
33. Timing the Initiation of Multiple Myeloma
34. Igcaller: Reconstructing the Rearranged Immunoglobulin Gene in Lymphoid Neoplasms from Whole-Genome Sequencing Data
35. Life History of Normal Human Lymphocytes Revealed By Somatic Mutations
36. Whole Genome Profiling of Adult B-Other Acute Lymphoblastic Leukaemia on the UKALL14 Trial
37. Transgenic overexpression of the CC chemokine CCL21 disrupts T-cell migration
38. Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia
39. Mosaic DNMT3A Germline Mutation As a Model for Mutant DNMT3A Competitive Advantage in the Blood Lineage
40. Modelling the Progression of a Preleukemic Stage to Overt Leukemia in Children with Down Syndrome
41. The Landscape of Structural Variant Signatures in Multiple Myeloma Identifies Distinct Disease Subgroups with Implications for Pathogenesis
42. The Complex Landscape of Rearrangements in Smoldering and Symptomatic Multiple Myeloma Revealed By Whole-Genome Sequencing
43. Nongenetic stochastic expansion of JAK2V617F-homozygous subclones in polycythemia vera?
44. T-bet: the first master regulator for lymphocyte homing commitment?
45. Sf3b1 K700E Mutation Impairs Pre-mRNA Splicing and Definitive Hematopoiesis in a Conditional Knock-in Mouse Model
46. Personally Tailored Risk Prediction of AML Based on Comprehensive Genomic and Clinical Data
47. Genomic Landscape and Its Prognostic Implications in Multiple Myeloma Using a Targeted Sequencing Approach
48. An Integrative Genomics Approach Uncovers the Basis of Resistance to AZA Therapy in MDS and CMML
49. Somatic Mutations in MDS Patients Are Associated with Clinical Features and Predict Prognosis Independent of the IPSS-R: Analysis of Combined Datasets from the International Working Group for Prognosis in MDS-Molecular Committee
50. Clincial and Genetic Landscapes Differ Between IGH-CRLF2 and P2RY8-CRLF2 Acute Lymphoblastic Leukaemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.